{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["32(3)"],"submitter":["deLaforcade A"],"pubmed_abstract":["Objectives
To expand the number of conditions and interventions explored for their associations with thrombosis in the veterinary literature and to provide the basis for prescribing recommendations.Design
A population exposure comparison outcome format was used to represent patient, exposure, comparison, and outcome. Population Exposure Comparison Outcome questions were distributed to worksheet authors who performed comprehensive searches, summarized the evidence, and created guideline recommendations that were reviewed by domain chairs. The revised guidelines then underwent the Delphi survey process to reach consensus on the final guidelines. Diseases evaluated in this iteration included heartworm disease (dogs and cats), immune-mediated hemolytic anemia (cats), protein-lo"],"journal":["Journal of veterinary emergency and critical care (San Antonio, Tex. : 2001)"],"pagination":["289-314"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9322658"],"repository":["biostudies-literature"],"pubmed_title":["2022 Update of the Consensus on the Rational Use of Antithrombotics and Thrombolytics in Veterinary Critical Care (CURATIVE) Domain 1- Defining populations at risk."],"pmcid":["PMC9322658"],"pubmed_authors":["Blais MC","Koenigshof A","Li R","Sharp CR","Boyd C","deLaforcade A","Chan DL","Bacek L","Brainard BM","Hoareau GL","Rozanski E","Lynch A","Cortellini S","Goggs R","Ralph A"],"additional_accession":[]},"is_claimable":false,"name":"2022 Update of the Consensus on the Rational Use of Antithrombotics and Thrombolytics in Veterinary Critical Care (CURATIVE) Domain 1- Defining populations at risk.","description":"Objectives
To expand the number of conditions and interventions explored for their associations with thrombosis in the veterinary literature and to provide the basis for prescribing recommendations.Design
A population exposure comparison outcome format was used to represent patient, exposure, comparison, and outcome. Population Exposure Comparison Outcome questions were distributed to worksheet authors who performed comprehensive searches, summarized the evidence, and created guideline recommendations that were reviewed by domain chairs. The revised guidelines then underwent the Delphi survey process to reach consensus on the final guidelines. Diseases evaluated in this iteration included heartworm disease (dogs and cats), immune-mediated hemolytic anemia (cats), protein-lo","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 May","modification":"2025-05-18T13:41:17.361Z","creation":"2025-05-18T13:41:17.361Z"},"accession":"S-EPMC9322658","cross_references":{"pubmed":["35499966"],"doi":["10.1111/vec.13204"]}}